[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI964251A - Menetelmä nukleosidianalogien valmistamiseksi diastereoselektiivisesti - Google Patents

Menetelmä nukleosidianalogien valmistamiseksi diastereoselektiivisesti Download PDF

Info

Publication number
FI964251A
FI964251A FI964251A FI964251A FI964251A FI 964251 A FI964251 A FI 964251A FI 964251 A FI964251 A FI 964251A FI 964251 A FI964251 A FI 964251A FI 964251 A FI964251 A FI 964251A
Authority
FI
Finland
Prior art keywords
nucleoside analogs
diastereoselective preparation
diastereoselective
preparation
nucleoside
Prior art date
Application number
FI964251A
Other languages
English (en)
Swedish (sv)
Other versions
FI964251A0 (fi
FI120401B (fi
Inventor
Michael David Goodyear
P Owen Dwyer
Malcolm Leithead Hill
Andrew Jonathan Whitehead
Roy Hornby
Peter Hallett
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267157&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI964251(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9408112A external-priority patent/GB9408112D0/en
Priority claimed from GB9408091A external-priority patent/GB9408091D0/en
Priority claimed from GB9408103A external-priority patent/GB9408103D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI964251A0 publication Critical patent/FI964251A0/fi
Publication of FI964251A publication Critical patent/FI964251A/fi
Application granted granted Critical
Publication of FI120401B publication Critical patent/FI120401B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI964251A 1994-04-23 1996-10-22 Menetelmä nukleosidianalogien valmistamiseksi diastereoselektiivisesti FI120401B (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB9408112A GB9408112D0 (en) 1994-04-23 1994-04-23 Process
GB9408091A GB9408091D0 (en) 1994-04-23 1994-04-23 Process
GB9408091 1994-04-23
GB9408112 1994-04-23
GB9408103 1994-04-23
GB9408103A GB9408103D0 (en) 1994-04-23 1994-04-23 Chemical compounds
EP9501503 1995-04-21
PCT/EP1995/001503 WO1995029174A1 (en) 1994-04-23 1995-04-21 Process for the diastereoselective synthesis of nucleoside analogues

Publications (3)

Publication Number Publication Date
FI964251A0 FI964251A0 (fi) 1996-10-22
FI964251A true FI964251A (fi) 1996-10-22
FI120401B FI120401B (fi) 2009-10-15

Family

ID=27267157

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964251A FI120401B (fi) 1994-04-23 1996-10-22 Menetelmä nukleosidianalogien valmistamiseksi diastereoselektiivisesti

Country Status (30)

Country Link
US (2) US6051709A (fi)
EP (1) EP0757684B1 (fi)
JP (2) JP4056558B2 (fi)
KR (1) KR100241842B1 (fi)
CN (2) CN1290841C (fi)
AP (1) AP704A (fi)
AT (1) ATE181326T1 (fi)
AU (1) AU696612B2 (fi)
BG (1) BG62810B1 (fi)
BR (1) BR9507499A (fi)
CZ (1) CZ293827B6 (fi)
DE (1) DE69510347T2 (fi)
DK (1) DK0757684T3 (fi)
EE (1) EE03442B1 (fi)
ES (1) ES2133769T3 (fi)
FI (1) FI120401B (fi)
GR (1) GR3031043T3 (fi)
HK (1) HK1004221A1 (fi)
HU (1) HU218044B (fi)
IL (1) IL113432A (fi)
IS (1) IS1844B (fi)
NO (2) NO307179B1 (fi)
NZ (1) NZ285396A (fi)
PL (1) PL180090B1 (fi)
RO (2) RO118714B1 (fi)
RU (1) RU2158736C2 (fi)
SK (1) SK281327B6 (fi)
TW (1) TW487704B (fi)
UA (1) UA43362C2 (fi)
WO (1) WO1995029174A1 (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684164A (en) * 1988-04-11 1997-11-04 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
BR9510327A (pt) * 1994-10-22 1998-11-10 Chong Kun Dang Corp Derivados de nucleosídeos e seu processo de preparo
GB9506644D0 (en) * 1995-03-31 1995-05-24 Wellcome Found Preparation of nucleoside analogues
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
RU2244712C2 (ru) * 1998-08-12 2005-01-20 Гайлид Сайенсиз, Инк. Способ получения 1,3-оксатиоланового нуклеозида, способ получения производного 1,3-оксатиоланил-5-она
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
AU2002335489B2 (en) 2001-03-01 2008-06-05 Abbott Laboratories Polymorphic and other crystalline forms of cis-FTC
CA2351049C (en) 2001-06-18 2007-03-13 Brantford Chemicals Inc. Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
WO2003027106A1 (en) * 2001-09-25 2003-04-03 Cadila Healthcar Limited Process for the preparation of crystalline polymorph ii of lamivudine
ITMI20030578A1 (it) * 2003-03-24 2004-09-25 Clariant Lsm Italia Spa Processo ed intermedi per la preparazione di emtricitabina
US20050187913A1 (en) 2003-05-06 2005-08-25 Yoram Nelken Web-based customer service interface
CN101307048B (zh) 2007-05-18 2011-03-23 上海迪赛诺医药发展有限公司 立体选择性制备拉米夫定的方法
US20100190982A1 (en) * 2007-09-17 2010-07-29 Janardhana Rao Vascuri Process for the preparation of lamivudine form i
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
BRPI0820222A2 (pt) * 2007-11-29 2015-06-16 Ranbaxy Lab Ltd Forma i cristalina estável de lamivudina e processo de preparação
WO2009069011A1 (en) 2007-11-29 2009-06-04 Ranbaxy Laboratories Limited Process for the preparation of substituted 1,3-oxathiolanes
US20100311961A1 (en) * 2007-11-29 2010-12-09 Ranbaxy Laboratories Limited Process and intermediates for the preparation of substituted 1,3-oxathiolanes, especially lamivudine
US8350030B2 (en) * 2007-12-07 2013-01-08 Matrix Laboratories Limited Process for producing 5-fluoro-1-(2R, 5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
CN101391997B (zh) * 2008-09-18 2010-12-22 江苏科本医药化学有限公司 一种恩曲他滨中间体的合成方法
CN101362752B (zh) * 2008-09-18 2011-12-28 浙江教育学院 一种拉米夫定中间体的合成方法
WO2010082128A1 (en) 2009-01-19 2010-07-22 Aurobindo Pharma Limited Process for the preparation of cis-nucleoside derivative
KR101474570B1 (ko) 2009-04-13 2014-12-19 주식회사 대희화학 라미부딘의 신규한 중간체 및 이의 제조방법
CN101544632B (zh) * 2009-04-24 2011-09-07 湖南千金湘江药业股份有限公司 拉米夫定非对映选择合成方法
DK2488516T3 (en) 2009-10-14 2015-05-26 Mylan Lab Ltd Method of producing lamivudine and novel salts in the preparation thereof
HRP20240168T1 (hr) 2010-01-27 2024-04-26 Viiv Healthcare Company Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije
US20120295930A1 (en) 2010-02-03 2012-11-22 Shankar Rama Novel process for the preparation of cis-nucleoside derivative
CN102167696B (zh) * 2010-02-25 2013-09-18 南京正大天晴制药有限公司 拉米夫定草酸盐及其制备方法
WO2011107920A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited A process for stereoselective synthesis of 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
CN101830893A (zh) * 2010-05-31 2010-09-15 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备工艺
CN102399213A (zh) * 2010-09-08 2012-04-04 重庆医药工业研究院有限责任公司 拉米夫定单邻苯二甲酸盐及其合成方法
WO2012062835A1 (en) 2010-11-12 2012-05-18 Glaxo Wellcome Manufacturing Pte Ltd Novel pharmaceutical compositions
WO2012137227A2 (en) 2011-04-08 2012-10-11 Laurus Labs Private Limited Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
CN102796088B (zh) * 2012-05-21 2015-06-10 湖南千金湘江药业股份有限公司 一种拉米夫定的制备方法
CN103450166A (zh) * 2012-05-31 2013-12-18 上海迪赛诺药业有限公司 制备核苷化合物的方法
CN103864835A (zh) * 2013-03-26 2014-06-18 安徽贝克联合制药有限公司 一种提高拉米夫定中间体立体选择性制备方法
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
CN103694231A (zh) * 2013-11-28 2014-04-02 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备方法
US9571109B2 (en) * 2015-03-27 2017-02-14 International Business Machines Corporation Voltage controlled oscillator runaway prevention
CN106146481A (zh) * 2015-04-07 2016-11-23 江苏普信制药有限公司 一种核苷类似物的制备方法
CN105037340B (zh) * 2015-07-14 2018-08-10 福建广生堂药业股份有限公司 一种拉米夫定关键中间体手性异构体杂质的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5684164A (en) * 1988-04-11 1997-11-04 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
WO1994014802A1 (en) * 1989-02-08 1994-07-07 Biochem Pharma Inc. Process for preparing substituted 1,3-oxathiolanes with antiviral properties
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
DE19875016I2 (de) 1991-05-16 2004-07-01 Glaxo Group Ltd Nukleosidanalogen enthaltende Antiviren-Zubereitungen.
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues

Also Published As

Publication number Publication date
EP0757684A1 (en) 1997-02-12
BG62810B1 (bg) 2000-08-31
EE03442B1 (et) 2001-06-15
NO964487D0 (no) 1996-10-22
FI964251A0 (fi) 1996-10-22
TW487704B (en) 2002-05-21
AU696612B2 (en) 1998-09-17
CN1290841C (zh) 2006-12-20
US6329522B1 (en) 2001-12-11
ATE181326T1 (de) 1999-07-15
NO313096B1 (no) 2002-08-12
KR100241842B1 (ko) 2000-03-02
RO118714B1 (ro) 2003-09-30
IL113432A0 (en) 1995-07-31
BG100916A (en) 1997-07-31
NO307179B1 (no) 2000-02-21
AP9600871A0 (en) 1996-10-31
US6051709A (en) 2000-04-18
FI120401B (fi) 2009-10-15
RU2158736C2 (ru) 2000-11-10
HU9602925D0 (en) 1996-12-30
AP704A (en) 1998-12-04
DE69510347D1 (de) 1999-07-22
PL180090B1 (pl) 2000-12-29
NO964487L (no) 1996-12-17
WO1995029174A1 (en) 1995-11-02
CZ293827B6 (cs) 2004-08-18
CN1500782A (zh) 2004-06-02
CZ309696A3 (en) 1997-04-16
NO995646L (no) 1999-11-17
GR3031043T3 (en) 1999-12-31
BR9507499A (pt) 1997-09-23
PL316904A1 (en) 1997-02-17
NO995646D0 (no) 1999-11-17
DK0757684T3 (da) 2000-01-17
HUT76296A (en) 1997-07-28
NZ285396A (en) 1998-10-28
IL113432A (en) 2000-11-21
RO117916B1 (ro) 2002-09-30
CN1149871A (zh) 1997-05-14
EE9600134A (et) 1997-04-15
HU218044B (hu) 2000-05-28
SK281327B6 (sk) 2001-02-12
IS4366A (is) 1996-09-27
EP0757684B1 (en) 1999-06-16
CN1151146C (zh) 2004-05-26
IS1844B (is) 2003-01-30
DE69510347T2 (de) 1999-11-18
HK1004221A1 (en) 1998-11-20
JP4056558B2 (ja) 2008-03-05
ES2133769T3 (es) 1999-09-16
JP2007217425A (ja) 2007-08-30
AU2447195A (en) 1995-11-16
SK135596A3 (en) 1997-07-09
UA43362C2 (uk) 2001-12-17
JPH10502615A (ja) 1998-03-10

Similar Documents

Publication Publication Date Title
FI964251A (fi) Menetelmä nukleosidianalogien valmistamiseksi diastereoselektiivisesti
KR960704082A (ko) 저 잔자성 재료로 이루어진 하나이상의 부재의 처리방법(Method to process at least one member of low-retentivity)
DK0807086T3 (da) Fremgangsmåde til fremstilling af hydrotalciter
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
NO994757L (no) Fremgangsmåte for oral administrasjon av proteiner
DK0754756T3 (da) Fremgangsmåde til fremstilling af L-lysin
DK0797542T3 (da) Fremgangsmåde til fremstilling af aluminosilikatderivater
DK1032565T3 (da) Fremgangsmåde til fremstilling af derivater af taxoid-klassen
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
DE69518743D1 (de) Modifizierung von nukleotidanalogen
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
EE04154B1 (et) Omeprasooli valmistamise meetod
DK0789767T3 (da) Fremgangsmåde til fremstilling af oprensede papilomavirusproteiner
FI95036B (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
IT1272922B (it) Procedimento per la preparazione di composti metallocenici
ITBO920210A0 (it) Metodo per la separazione di due file di pacchetti di sigarette
NO994049D0 (no) Metode for å fremstille farmasöytiske forbindelser
NO20002168D0 (no) FremgangsmÕte for fremstilling av chirale nukleosidanaloger
DK0971919T3 (da) Fremgangsmåde til fremstilling af 4H-4-oxo-quinolizin-3-carboxylsyrederivater
EE9600007A (et) Diltiaseemi valmistamise meetod
DK1015442T3 (da) Fremgangsmåde til fremstilling af 3-isochromanon
EE04007B1 (et) Meetod kristalliliste ainete puhastamiseks
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
FI942338A0 (fi) Menetelmä epäpuhtaan alumiinioksidin puhdistamiseksi uuttamalla

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120401

Country of ref document: FI

MA Patent expired